P. Dias

发表

Mutation of Thr 115 in MyoD Positively Regulates Function in Murine Fibroblasts and Human Rhabdomyosarcoma Cells 1

P. Houghton, Uu, P. Dias, 2005 .

Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.

P. Houghton, P. Dias, L. N. Liu, 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.

C. Cordon-Cardo, P. Houghton, J. Rosai, 1994, The American journal of pathology.

Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.

P. Houghton, D. Shapiro, L. Shapiro, 1994, The Journal of clinical investigation.

Immunohistochemical analysis of the distribution of MyoD1 in muscle biopsies of primary myopathies and neurogenic atrophy

P. Houghton, D. Parham, T. Bertorini, 1994, Acta Neuropathologica.

Comparison of MyoD1 Immunostaining of Pediatric Tumors Using Frozen or Paraffin-Embedded Sections

P. Houghton, D. Parham, P. Mukunyadzi, 1999 .

Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.

D. Parham, J. Jenkins, V. Savell, 1998, The American journal of pathology.

Rapid Communication Myogenic Regulatory Protein (MyoDi) Expression inChildhood Solid Tumors: Diagnostic Utility inRhabdomyosarcoma

P. Dias, 1990 .

Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.

P. Houghton, D. Shapiro, D. Parham, 1990, The American journal of pathology.

the Type I Insulin-like Growth Factor Receptor Rhabdomyosarcoma Cells through Inhibition of Signaling via Rapamycin Selectively Inhibits the Growth of Childhood

D. Shapiro, M. Dilling, P. Dias, 2007 .

Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.

P. Houghton, G. Germain, D. Shapiro, 1994, Cancer research.

MyoD1 protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature.

P. Houghton, J. Rosai, D. Shapiro, 1991, The American journal of surgical pathology.

The molecular basis of skeletal muscle differentiation.

P. Houghton, M. Dilling, P. Dias, 1994, Seminars in diagnostic pathology.

Desmin Positivity in Primitive Neuroectodermal Tumors of Childhood

D. Parham, P. Houghton, J. Rutledge, 1992, The American journal of surgical pathology.

Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.

Bin Chen, Sujay K. Singh, P. Houghton, 2000, The American journal of pathology.

Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility.

S. Tapscott, P. Houghton, D. Shapiro, 1992, Cancer research.

Gonadal mixed germ cell tumor combined with a large hemangiomatous lesion.

P. Houghton, D. Parham, P. Dias, 1995 .

Stromal scoring in advanced colon and rectal cancer: Stroma-rich tumors and their association with aggressive phenotypes

P. Dias, D. Silva, M. Queiroga, 2022 .

Alpha 2a-interferon-induced differentiation of human alveolar rhabdomyosarcoma cells: correlation with down-regulation of the insulin-like growth factor type I receptor.

P. Houghton, J. Houghton, P. Dias, 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.

E. Oldfield, A. Saxena, I. Ali, 1992, Cancer research.